Cargando…

Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study

BACKGROUND: Adrenocortical carcinoma (ACC) is a rare tumor in which prognostic factors are still not well established. Programmed Death Ligand-1 (PD-L1) expression in ACC and its association with clinico-pathological features and survival outcomes are unknown. METHODS: Formalin-fixed paraffin-embedd...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fay, André P, Signoretti, Sabina, Callea, Marcella, Telό, Gabriela H, McKay, Rana R, Song, Jiaxi, Carvo, Ingrid, Lampron, Megan E, Kaymakcalan, Marina D, Poli-de-Figueiredo, Carlos E, Bellmunt, Joaquim, Hodi, F Stephen, Freeman, Gordon J, Elfiky, Aymen, Choueiri, Toni K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357210/ https://www.ncbi.nlm.nih.gov/pubmed/25767716 http://dx.doi.org/10.1186/s40425-015-0047-3

Ejemplares similares

Correlation of Apobec Mrna Expression with overall Survival and pd-l1 Expression in Urothelial Carcinoma
por: Mullane, Stephanie A., et al.
Publicado: (2016)

Cell Kinetic Studies Fail to Identify Sequentially Proliferating Progenitors as the Major Source of Epithelial Renewal in the Adult Murine Prostate
por: Pignon, Jean-Christophe, et al.
Publicado: (2015)

Exploratory Circular RNA Profiling in Adrenocortical Tumors
por: Turai, Péter István, et al.
Publicado: (2022)

In Reply
por: de Velasco, Guillermo, et al.
Publicado: (2017)

Identification of ALK Gene Alterations in Urothelial Carcinoma
por: Bellmunt, Joaquim, et al.
Publicado: (2014)

Landscape of tumor-infiltrating T cell repertoire of human cancers
por: Li, Bo, et al.
Publicado: (2016)

Differential side effects profile in patients with mCRPC treated with abiraterone or enzalutamide: a meta-analysis of randomized controlled trials
por: Moreira, Raphael B., et al.
Publicado: (2017)

Differential expression of c-Met between primary and metastatic sites in clear-cell renal cell carcinoma and its association with PD-L1 expression
por: Lalani, Aly-Khan A., et al.
Publicado: (2017)

Somatic Copy Number Abnormalities and Mutations in PI3K/AKT/mTOR Pathway Have Prognostic Significance for Overall Survival in Platinum Treated Locally Advanced or Metastatic Urothelial Tumors
por: Bellmunt, Joaquim, et al.
Publicado: (2015)

Impact of Geographic Regions on Overall Survival in Patients With Metastatic Renal Cell Carcinoma: Results From an International Clinical Trials Database
por: Fay, Andre P., et al.
Publicado: (2018)

Mechanisms of acquired resistance to rapalogs in metastatic renal cell carcinoma
por: Hamieh, Lana, et al.
Publicado: (2018)

QTc interval prolongation with vascular endothelial growth factor receptor tyrosine kinase inhibitors
por: Ghatalia, P, et al.
Publicado: (2015)

Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy
por: Bellmunt, Joaquim, et al.
Publicado: (2016)

Inhibition of ALK1 signaling with dalantercept combined with VEGFR TKI leads to tumor stasis in renal cell carcinoma
por: Wang, Xiaoen, et al.
Publicado: (2016)

Assessment of the Ecological Association between Tobacco Smoking Exposure and Bladder Cancer Incidence over the Past Half-Century in the United States
por: Seisen, Thomas, et al.
Publicado: (2023)

A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinoma
por: Nassar, Amin H., et al.
Publicado: (2019)

Stem-Like Signature Predicting Disease Progression in Early Stage Bladder Cancer. The Role of E2F3 and SOX4
por: Bellmunt, Joaquim
Publicado: (2018)

Adrenocortical Carcinoma
por: Berruti, Alfredo, et al.
Publicado: (2021)

Involvement of 27-Hydroxycholesterol in Mitotane Action on Adrenocortical Carcinoma
por: Germano, Antonina, et al.
Publicado: (2020)

Metformin as a new anti-cancer drug in adrenocortical carcinoma
por: Poli, Giada, et al.
Publicado: (2016)

Correction to: Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma
por: Powles, Thomas, et al.
Publicado: (2021)

Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma
por: Powles, Thomas, et al.
Publicado: (2021)

Clinical and Pathological Features of Metastatic Adrenocortical Carcinoma
por: Guiomar, Joana Reis, et al.
Publicado: (2021)

A Case of Oncocytic Adrenocortical Neoplasm of Borderline (Uncertain) Malignant Potential
por: Shenouda, Mina, et al.
Publicado: (2016)

Epithelial and Mesenchymal Markers in Adrenocortical Tissues: How Mesenchymal Are Adrenocortical Tissues?
por: Sbiera, Iuliu, et al.
Publicado: (2021)

Was It an Adrenocortical Adenoma or an Adrenocortical Carcinoma? Limitation of the Weiss Scoring System in Determining the Malignant Potential of Adrenocortical Tumor: Report on Two Cases
por: Wong, Cheuk-Lik, et al.
Publicado: (2022)

Genomic landscape of pediatric adrenocortical tumors
por: Pinto, Emilia M., et al.
Publicado: (2015)

Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
por: Miao, Diana, et al.
Publicado: (2018)

Mitotane in adrenocortical carcinoma.
por: Vassilopoulou-Sellin, R., et al.
Publicado: (1994)

Drugs and Adrenocortical Function
por: Vogt, Marthe
Publicado: (1957)

Adrenocortical Causes of Hypertension
por: Moraitis, Andreas, et al.
Publicado: (2011)

Pediatric adrenocortical carcinoma
por: Ilanchezhian, Maran, et al.
Publicado: (2022)

Efficacy of Savolitinib vs Sunitinib in Patients With MET-Driven Papillary Renal Cell Carcinoma: The SAVOIR Phase 3 Randomized Clinical Trial
por: Choueiri, Toni K., et al.
Publicado: (2020)

Exploring the Dimensionality of the Social Skills Improvement System Using Exploratory Graph Analysis and Bifactor-(S − 1) Modeling
por: Panayiotou, Margarita, et al.
Publicado: (2020)

Development and Application of a Machine Learning Approach to Assess Short-term Mortality Risk Among Patients With Cancer Starting Chemotherapy
por: Elfiky, Aymen A., et al.
Publicado: (2018)

Visceral Metastasis Predicts Response to New Hormonal Agents in Metastatic Castration-Sensitive Prostate Cancer
por: Yekedüz, Emre, et al.
Publicado: (2023)

Abnormal frontostriatal connectivity and serotonin function in gambling disorder: A preliminary exploratory study
por: Bellmunt-Gil, Albert, et al.
Publicado: (2023)

Histological scores and tumor size on stage II in adrenocortical carcinomas
por: Oliveira, Rui Caetano, et al.
Publicado: (2021)

The Effect of Technology-Based Interventions on Pain, Depression, and Quality of Life in Patients With Cancer: A Systematic Review of Randomized Controlled Trials
por: Agboola, Stephen O, et al.
Publicado: (2015)

Improving Outcomes in Cancer Patients on Oral Anti-Cancer Medications Using a Novel Mobile Phone-Based Intervention: Study Design of a Randomized Controlled Trial
por: Agboola, Stephen, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_00hif3qivvo6skm0km5qdh1vq7